Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. Reply

N Engl J Med. 2023 Dec 28;389(26):2497-2498. doi: 10.1056/NEJMc2312559.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Artemisinins* / pharmacology
  • Artemisinins* / therapeutic use
  • Eritrea / epidemiology
  • Humans
  • Malaria, Falciparum* / drug therapy
  • Malaria, Falciparum* / epidemiology
  • Plasmodium falciparum / genetics
  • Prevalence

Substances

  • artemisinin
  • Artemisinins